Lexaria Bioscience Enters CBD License Agreement with Universal Hemp
Kelowna, British Columbia – July 11, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that it has entered a…
Lexaria Bioscience Enters CBD Beverage License Agreement with Nic’s Beverages
Kelowna, British Columbia – July 10, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that it has entered a…
Lexaria Bioscience Engages The Richmond Club to Provide Media Services
Kelowna, British Columbia – July 5, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that in has retained Streetwise…
Lexaria Announces 2019 Annual and Special Meeting Results
Kelowna, British Columbia – June 21, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces the results of the 2019 Annual and Special Meeting (the…
Lexaria Bioscience Announces new DehydraTECH Innovation, Files New Patents
New Enhanced DehydraTECHTM formulation delivers 8X more CBD into blood and over 19X more CBD into brain tissue than standard industry formulations. Kelowna, British Columbia – June 4, 2019 –…
Combining Lexaria’s DehydraTECHTM with Nanotech Delivers Increased Quantities of CBD into Brain Tissue
• Lexaria’s patented DehydraTECH combined with nanoemulsion formulation delivers 1,137% more CBD KELOWNA, British Columbia – May 28, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or…
Lexaria Bioscience Announces the Issuance of Options and Warrants
Kelowna, British Columbia – May 23, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that on May 22, 2019…
Lexaria Bioscience and Nuka Enterprises’ 1906 Expand Cannabis Product Relationship
1906 fast-acting edibles products, powered by Lexaria’s DehydraTECH technology, will expand across the US in 2019 and 2020 Kelowna, British Columbia – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX), an innovator…
Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations
The DehydraTECH formulation delivered measurable quantities of cannabidiol (“CBD”) into blood in as little as 2 minutes; Lexaria’s technology delivered more CBD to bloodstream in 15 minutes than conventional medium…
Lexaria Bioscience Announces CBD-Beverage Formulation License Agreement with Nevada-Based Company
Kelowna, British Columbia – May 7, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that it has entered a…